• Navigating Cardiac Myosin Therapy: Insights for NYHA Class II HCM Patients

  • Mar 13 2024
  • Duración: 39 m
  • Podcast

Navigating Cardiac Myosin Therapy: Insights for NYHA Class II HCM Patients  Por  arte de portada

Navigating Cardiac Myosin Therapy: Insights for NYHA Class II HCM Patients

  • Resumen

  • When should we make the critical decision to start Cardiac Myosin therapy in NYHA Class II HCM patients? Today, Dr. Patrycja Galazka is joined by Dr. Sara Saberi, Assistant Associate Professor in Cardiovascular Medicine and co-director of the Inherited Cardiomyopathy Program at the Frankel Cardiovascular Center. Together, we dive into the intricate world of Cardiac Myosin Inhibitors, addressing this vital question.

    In the ever-changing landscape of HCM management, this episode offers a beacon of clarity. Whether you're a healthcare professional dedicated to improving patient outcomes or someone personally navigating the challenges of HCM, our conversation provides essential insights. Join us for a discussion that could reshape your approach to HCM care.

    In the Thick of It is brought to you by the HCM Society and is produced by Earfluence.

    Más Menos
activate_primeday_promo_in_buybox_DT

Lo que los oyentes dicen sobre Navigating Cardiac Myosin Therapy: Insights for NYHA Class II HCM Patients

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.